Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Zimran

Showing results (131-140 of 238) with videos related to

Pageof 24
Sort By:
American Journal of Hematology|July 11, 2018
Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher diseaseAri Zimran, Shoshana Revel-Vilk, Michal Becker-Cohen, et al.
Journal of Parkinson'S Disease|September 26, 2015
Color Discrimination in Patients with Gaucher Disease and Parkinson DiseaseShlomi Simon-Tov, Tama Dinur, Nir Giladi, et al.
British Journal of Haematology|March 4, 2006
Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher diseaseItai Magal, Ehud Lebel, Gheona Altarescu, et al.
Journal of Clinical Medicine|December 23, 2023
Cancer Risk in Patients with Gaucher Disease Using Real-World DataShoshana Revel-Vilk, Ari Zimran, Majdolen Istaiti, et al.
British Journal of Haematology|March 16, 2011
Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleedingGalia Spectre, Batia Roth, Galia Ronen, et al.
Blood Cells, Molecules & Diseases|November 15, 2016
Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trialsAri Zimran, Deborah Elstein, Derlis E Gonzalez, et al.
Blood Cells, Molecules & Diseases|September 16, 2003
The 1604A (R496H) mutation in Gaucher disease: genotype/phenotype correlationAriel Brautbar, Deborah Elstein, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|December 26, 2012
Phenotype in patients with Gaucher disease and Parkinson diseaseEli Ben Chetrit, Roy N Alcalay, Bettina Steiner-Birmanns, et al.
Blood Cells, Molecules & Diseases|December 3, 2014
Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher diseaseAri Zimran, Derlis Emilio Gonzalez-Rodriguez, Aya Abrahamov, et al.
Mhealth|November 10, 2025
MyGauch<sup>TM</sup>: a patient-centered digital health app for Gaucher diseaseMajdolen Istaiti, Elena Shulman, Tama Dinur, et al.
Pageof 24

Showing results (131-140 of 238) with videos related to

Sort By:
Pageof 24
American Journal of Hematology|July 11, 2018
Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher diseaseAri Zimran, Shoshana Revel-Vilk, Michal Becker-Cohen, et al.
Journal of Parkinson'S Disease|September 26, 2015
Color Discrimination in Patients with Gaucher Disease and Parkinson DiseaseShlomi Simon-Tov, Tama Dinur, Nir Giladi, et al.
British Journal of Haematology|March 4, 2006
Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher diseaseItai Magal, Ehud Lebel, Gheona Altarescu, et al.
Journal of Clinical Medicine|December 23, 2023
Cancer Risk in Patients with Gaucher Disease Using Real-World DataShoshana Revel-Vilk, Ari Zimran, Majdolen Istaiti, et al.
British Journal of Haematology|March 16, 2011
Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleedingGalia Spectre, Batia Roth, Galia Ronen, et al.
Blood Cells, Molecules & Diseases|November 15, 2016
Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trialsAri Zimran, Deborah Elstein, Derlis E Gonzalez, et al.
Blood Cells, Molecules & Diseases|September 16, 2003
The 1604A (R496H) mutation in Gaucher disease: genotype/phenotype correlationAriel Brautbar, Deborah Elstein, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases|December 26, 2012
Phenotype in patients with Gaucher disease and Parkinson diseaseEli Ben Chetrit, Roy N Alcalay, Bettina Steiner-Birmanns, et al.
Blood Cells, Molecules & Diseases|December 3, 2014
Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher diseaseAri Zimran, Derlis Emilio Gonzalez-Rodriguez, Aya Abrahamov, et al.
Mhealth|November 10, 2025
MyGauch<sup>TM</sup>: a patient-centered digital health app for Gaucher diseaseMajdolen Istaiti, Elena Shulman, Tama Dinur, et al.
Pageof 24